Microtissues, Inc.

Since 2010, Microtissues, Inc has been selling the 3D PetriDish, a reusable micro-mold platform system for forming multi-cellular spheroids and organoids from primary cells, cancer cells, stem cells and cell lines. Our products are distributed worldwide by Millipore Sigma and have been used in over 200 peer-reviewed publications, a list which is available on our website.

Bioprinting Laboratories

Bioprinting Labs’ pillar/perfusion plates enable robust and reproducible organoid culture and in situ analysis. Our products streamline organoid-based assays by facilitating miniature organoid culture and enhancing organoid maturity through dynamic culture in the pillar/perfusion plates.

AIM Biotech

AIM Biotech is a leading bioengineering company, offering scalable, cost-effective 3D cell culture platforms, drug screening services, and customized assay development. By combining model realism and platform simplicity, AIM’s plug-and-play technologies empower drug developers to mimic human biology with precision, delivering clinically-relevant data.

Axol BioScience

Axol Bioscience are leaders in human iPSC products and services for CNS, PNS and cardiac research. Under ISO9001, we manufacture functional hiPSC-derived cells with multi-platform utility for MPS technology, alongside a “one-stop shop” of iPSC lines, services and custom assays.

Exir Bio

Exir Bio’s goal is to accelerate drug discovery, efficacy, and safety assessments by combining nonhuman primate (NHP) in vitro / in vivo models,
replacing, reducing, and refining (3R’s) the use of NHPs – necessary due to the global shortage of NHPs and in accordance with US Modernization Act
2.0.
Exir Bio has access to ~20,000 NHP’s / 8 species across several colonies in the US, all with known origin and bred in captivity per FDA and European
Union requirements.

Ncardia

For more than a decade, Ncardia has been pioneering innovations in human induced pluripotent stem cells (iPSC).